2023
DOI: 10.3390/molecules28041860
|View full text |Cite
|
Sign up to set email alerts
|

Designing Next-Generation Drug-like Molecules for Medicinal Applications

Abstract: The development of new drugs/drug candidates for medical treatment remains an exciting but challenging process as only a limited number of synthetic compounds fit well into the discovery and development process after multiple experiments and screening for their preclinical properties [...]

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 17 publications
0
2
0
Order By: Relevance
“…Compounds exhibiting drug-like molecule characteristics are predicted to induce biological activity and possess the ability to penetrate the cell membrane, reaching targets within the cytoplasmic environment. 31 Molecular docking aims to identify how ligands interact with the target domain. 32 In this study, grid docking is used with the position set at Center (Å) X: 2.746, Y: -25.031, Z: 16.706, Dimensions (Å) X: 105.798, Y: 83.933, Z: 106.561 to orient the ligand on the target.…”
Section: Discussionmentioning
confidence: 99%
“…Compounds exhibiting drug-like molecule characteristics are predicted to induce biological activity and possess the ability to penetrate the cell membrane, reaching targets within the cytoplasmic environment. 31 Molecular docking aims to identify how ligands interact with the target domain. 32 In this study, grid docking is used with the position set at Center (Å) X: 2.746, Y: -25.031, Z: 16.706, Dimensions (Å) X: 105.798, Y: 83.933, Z: 106.561 to orient the ligand on the target.…”
Section: Discussionmentioning
confidence: 99%
“…The similarity of query ligands with drug molecules in terms of several druglikeness rules such as Lipinski, Ghose, Veber, Egan, and Muegge was analyzed with Canonical SMILES input from garcinoxanthone, mangostin, and garcinone derivative compounds [34][35][36]. The results of the druglikeness analysis show that all query compounds from Garcinia mangostana L. are probable drug-like molecules because they fulfill at least 3 druglikeness rules such as Lipinski, Ghose, Veber, and Egan.…”
Section: Druglike Compoundsmentioning
confidence: 99%